Abstract
This chapter introduces the main families of protein phosphatases encoded by the human genome and discusses their classification, overall structure, regulation, and physiological functions in human health and diseases. The topics of redundancy, diversity, and dynamic expression in individual cell types are briefly introduced, and the importance of technological approaches to phosphatase research is emphasized.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hunter, T. (1998) The role of tyrosine phosphorylation in cell growth and disease. Harvey Lect. 94, 81–119.
Andersen, J. N., Jansen, P. G., Echwald, S. M., et al. (2004) A genomic perspective on PTPs: gene structure, pseudogenes, and genetic disease linkage. FASEB J. 18, 8–13.
Alonso, A., Sasin, J., Osterman, A., et al. (2004) The PTPs in the human genome. Cell 117, 699–711.
Bottini, N., Bottini, E., Gloria-Bottini, F., and Mustelin, T. (2002) LMPTP and human disease: in search of biochemical mechanisms. Arch. Immunol. Ther. Exp. (AITE) 50, 95–104.
Hunter, T. and Sefton, B. M. (1980) Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77, 1311–1315.
Chow, K., Ng, D., Stokes, R., and Johnson, P. (1994) Protein tyrosine phosphorylation in Mycobacterium tuberculosis. FEMS Microbiol. Lett. 124, 203–207.
Kennelly, P. J. (2003) Archaeal protein kinases and protein phosphatases: Insights from genomics and biochemistry. Biochem. J. 370, 373–389.
Cozzone, A. J., Grangeasse, C., Doublet, P., and Duclos, B. (2004) Protein phosphorylation on tyrosine in bacteria. Arch. Microbiol. 181, 171–181.
Walton, K. M. and Dixon, J. E. (1993) Protein tyrosine phosphatases. Annu. Rev. Biochem. 62, 101–120.
Tonks, N. K. and Neel, B. G. (1996) From form to function: signaling by PTPs. Cell 87, 365–368.
Mustelin, T., Vang, T., and Bottini, N. (2005) Protein tyrosine phosphatases and the immune response. Nat. Rev. Immunol. 5, 43–57.
Stoker, A. W. (2005) Protein tyrosine phosphatases and signaling. J. Endocrinol. 185, 19–33.
Kappert, K., Peters, K. G., Bohmer, F. D., and Ostman, A. (2005) Tyrosine phosphatases in vessel wall signaling. Cardiovasc. Res. 65, 587–598.
Rebay, I., Silver, S. J., and Tootle, T. L. (2005) New vision from Eyes absent: transcription factors as enzymes. Trends Genet. 21, 163–171.
Wong, W. and Scott, J. D. (2004) AKAP signalling complexes: focal points in space and time. Nat. Rev. Mol. Cell. Biol. 5, 959–970.
Cohen, P. T. (2002) Protein phosphatase 1: targeted in many directions. J. Cell. Sci. 115, 241–256.
Ceulemans, H. and Bollen, M. (2004) Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84, 1–39.
Feng, G. S. (1999) Shp-2 tyrosine phosphatase: Signaling one cell or many. Exp. Cell Res. 253, 47–54
Mustelin, T., Coggeshall, K. M., and Altman, A. (1989) Rapid activation of the T cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc. Natl. Acad. Sci. USA. 86, 6302–6306.
Bottini, N., Stefanini, L., Williams, S., et al. (2002) Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J. Biol. Chem. 277, 24,220–24,224.
Cote, J. F., Charest, A., Wagner, J., and Tremblay, M. L. (1998) Combination of gene targeting and substrate trapping to identify substrates of PTPs using PTP-PEST as a model. Biochemistry 37, 13,128–13,137.
Saxton, T. M., Henkemeyer, M., Gasca, S., et al. (1997) Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16, 2352–2364.
Gronda, M., Arab, S., Iafrate, B., Suzuki, H., and Zanke, B. (2001) Hematopoietic PTP suppresses extracellular stimulus-regulated kinase activation. Mol. Cell. Biol. 21, 6851–6858.
Elchebly, M., Payette, P., Michaliszyn, E., et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the PTP-1B gene. Science 283, 1544–1548.
You-Ten, K. E., Muise, E. S., Itie, A., et al. (1997) Impaired bone marrow microenvironment and immune function in T cell PTP-deficient mice. J. Exp. Med. 186, 683–693.
Byth, K. F., Conroy, L. A., Howlett, S., et al. (1996) CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development in the selection of CD4+CD8+ thymocytes and B-cell maturation. J. Exp. Med. 183, 1707–1718.
Wharram, B. L., Goyal, M., Gillespie, P. J., et al. (2000) Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. Clin. Invest. 106, 1281–1290.
Uetani, N., Kato, K., Ogura, H., et al. (2000) Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. EMBO J. 19, 2775–2785.
Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P. P. (1998) Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348–355.
Koop, E. A., Gebbink, M. F. B. G., Sweeney, T. E., et al. (2005) Impaired flow-induced dilation in mesenteric resistance arteries from receptor protein tyrosine phosphatase-μ-deficient mice. Am. J. Physiol. (Heart Circ. Physiol.) 288, H1218–H1223.
Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912–1934.
Schonthal, A. H. (1998) Role of PP2A in intracellular signal transduction pathways. Front. Biosci. 3, D1262–1273.
Lee, J. O. Yang, H., Georgescu, M. M., et al. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323–334.
Begley, M. J. Taylor, G. S., Kim, S. A., Veine, D. M., Dixon, J. E., and Stuckey, J. A. (2003) Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth Syndrome. Mol. Cell 12, 1391–1402.
Rayapureddi, J. P., Kattamuri, C., Chan, F. H., and Hegde, R. S. (2005) Characterization of a plant, tyrosine-specific phosphatase of the aspartyl class. Biochemistry 44, 751–8.
Roberts, A., Lee, S. Y., McCullagh, E., Silversmith, R. E., and Wemmer, D. E. (2005) Ybiv from Escherichia coli K12 is a HAD phosphatase. Proteins 58, 790–801.
Roberts, S. J., Stewart, A. J., Sadler, P. J., and Farquharson, C. (2004) Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem. J. 382, 59–65.
Allegrini, S., Scaloni, A., Careddu, M. G., et al. (2004) Mechanistic studies on bovine cytosolic 5′-nucleotidase II, an enzyme belonging to the HAD superfamily. Eur. J. Biochem. 271, 4881–4891.
Lunn, J. E., Ashton, A. R., Hatch, M. D., and Heldt, H. W. (2000) Purification, molecular cloning, and sequence analysis of sucrose-6F-phosphate phosphohydrolase from plants. Proc. Natl. Acad. Sci. USA 97, 12,914–12,919.
Cronin, A., Mowbray, S., Durk, H., et al. (2003) The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase. Proc. Natl. Acad. Sci. USA 100, 1552–1557.
Gohla, A., Birkenfeld, J., and Bokoch, G. M. (2005) Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics. Nat. Cell Biol. 7, 21–29.
Yeo, M., Lin, P. S., Dahmus, M. E., and Gill, G. N. (2003) A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates serine 5. J. Biol. Chem. 278, 26,078–26,085.
Peisach, E., Selengut, J. D., Dunaway-Mariano, D., and Allen, K. N. (2004) X-ray crystal structure of the hypothetical phosphotyrosine phosphatase MDP-1 of the haloacid dehalogenase superfamily. Biochemistry 43, 12,770–12,779.
Stewart, A. J., Schmid, R., Blindauer, C. A., Paisey, S. J., and Farquharson, C. (2003) Comparative modelling of human PHOSPHO1 reveals a new group of phosphatases within the haloacid dehalogenase superfamily. Protein Eng. 16, 889–895.
Allen, K. N. and Dunaway-Mariano, D. (2004) Phosphoryl group transfer: evolution of a catalytic scaffold. Trends Biochem. Sci. 29, 495–503.
Lahiri, S. D., Zhang, G., Dai, J., Dunaway-Mariano, D., and Allen, K. N. (2004) Analysis of the substrate specificity loop of the HAD superfamily cap domain. Biochemistry 43, 2812–2820.
Charbonneau, H., Tonks, N. K., Kumar, S., et al. (1989) Human placenta protein-tyrosine phosphatase: amino-acid sequence and relationship to a family of receptor-like proteins. Proc. Natl. Acad. Sci. USA 86, 5252–5256.
Maehama, T. and Dixon, J. E. (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13,375–13,378.
Wishart, M. J. and Dixon, J. E. (2002) PTEN and myotubularins phosphatases: from 3-phosphoinositide dephosphorylation to disease. Trends Cell Biol. 12, 579–585.
Alonso, A., Sasin, J., Burkhalter, S., et al. (2004) The minimal essential core of a cysteine-based PTP revealed by a novel 16-kDa VH1-like phosphatase, VHZ. J. Biol. Chem. 279, 35,768–35,774.
Bordo, D. and Bork, P. (2002) The rhodanese/Cdc25 phosphatase superfamily. Sequence-structure-function relations. EMBO Rep. 3, 741–746.
Alonso, A., Rojas, A., Godzik, A., and Mustelin, T. (2003) The dual-specific PTP family. Top. Curr. Genet. 5, 333–358.
Vincent, C., Duclos, B., Grangeasse, C., et al. (2000) Relationship between exopolysaccharide production and protein-tyrosine phosphorylation in Gram-negative bacteria. J. Mol. Biol. 304, 311–321.
Musumeci, L., Tautz, L., Perego, M., Mustelin, T., and Bottini, N. (2005) Characterization of the YfkJ protein tyrosine phosphatase of Bacillus subtilis and Bacillus anthracis. J. Bacteriol., in press.
Kashio, N., Matsumoto, W., Parker, S., and Rothstein, D.M. (1998). The second domain of the CD45 protein tyrosine phosphatase is critical for interleukin-2 secretion and substrate recruitment of TCRζ in vivo. J. Biol. Chem. 273, 33856–33863.
Bolino, A., Muglia, M., Conforti, F. L., et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25, 17–19.
Azzedine, H., Bolino, A., Taieb, T., et al. (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am. J. Hum. Genet. 72, 1141–1153.
Mustelin, T. and Hunter, T. (2002) Meeting at mitosis: cell cycle-specific regulation of c-Src by RPTPα Science’s STKE. http://stke.sciencemag.org/cgi/content/full/OC_sigtrans;2002/115/pe3.
Tailor, P., Williams, S., Gilman, J., Couture, C., and Mustelin, T. (1997) Regulation of the low molecular weight phosphotyrosine phosphatase (LMPTP) by phosphorylation at tyrosines 131 and 132. J. Biol. Chem. 272, 5371–5376.
Alonso, A., Rahmouni, S., Williams, S., et al. (2003) Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nat. Immunol. 4, 44–48.
Dorfman, K., Carrasco, D., Gruda, M., Ryan, C., Lira, S. A., and Bravo, R. (1996) Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 13, 925–931.
Hasegawa, K., Martin, F., Huang, G., Tumas, D., Diehl, L., and Chan, A. C. (2004) PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303, 685–689.
Saha, S., Bardelli, A., Buckhaults, P., et al. (2001) A phosphatase associated with metastasis of colorectal cancer. Science 294, 1343–1346.
Tartaglia, M., Mehler, E. L., Goldberg, R., et al. (2001) Mutations in PTPN11, encoding the PTP SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465–468
Minassian, B. A., Lee, J. R., Herbrick, J. A., et al. (1998) Mutations in a gene encoding a novel PTP cause progressive myoclonus epilepsy. Nat. Genet. 20, 171–174.
Laporte, J., Hu, L. J., Kretz, C., et al. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13, 175–182.
Tchilian, E. Z., Wallace, D. L., Wells, R. S., Flower, D. R., Morgan, G., and Beverley, P. C. L. (2001) A deletion in the gene encoding the CD45 antigen in a patient with SCID. J. Immunol. 166, 1308–1313.
Kung, C., Pingel, J. T., Heikinheimo, M., et al. (2000) Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat. Med. 6, 343–345.
Bottini, N., Musumeci, L., Alonso, A., et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat. Genet. 36, 337–338.
Smyth, D., Cooper, J. D., Collins, J. E., et al. (2004) Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53, 3020–3023.
Ladner, M. B., Bottini, N., Valdes, A. M., and Noble, J. A. (2005) Association of the single-nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum. Immunol. 66, 60–64.
Kawasaki, E., Hutton, J. C., and Eisenbarth, G. S (1996) Molecular cloning and characterization of the human transmembrane PTP homologue, phogrin, an autoantigen of type I diabetes. Biochem. Biophys. Res. Commun. 227, 440–447.
Begovich, A. B., Carlton, V. E., Honigberg, L. A., et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a PTP (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75, 330–337.
Kyogoku, C., Langefeld, C. D., Ortmann, W. A., et al. (2004) Genetic association of the R620W polymorphism of PTP PTPN22 with human SLE. Am. J. Hum. Genet. 75, 504–507.
Velaga, M. R., Wilson, V., Jennings, C. E., et al. (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J. Clin. Endocrinol. Metab. 89, 5862–5865.
Mena-Duran, A. V., Togo, S. H., Bazhenova, L., et al. (2005) SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic marker. Br. J. Haematol., 129, 791–794.
Fonatsch, C., Haase, D., Freund, M., Bartels, H., and Tesch, H. (1991) Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes? Cancer Genet. Cytogenet. 56, 243–253.
Zanke, B., Squire, J. Griesser, H. et al. (1994) A hematopoietic PTP (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1. Leukemia 8, 236–244.
Schweiger, S. and Schneider, R. (2003) The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome. Bioessays 25, 356–366.
Ito, A., Koma, Y.-I., and Watabe, K. (2003) A mutation in protein phosphatase type 2A as a cause of melanoma progression. Histol. Histopathol. 18, 1313–1319.
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., and Hahn, W. C. (2004) Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5, 127–136.
Tautz, L., Bruckner, S., Sareth, S., et al. (2005) Inhibition of Yersinia tyrosine phosphatase by furanyl salicylate compounds. J. Biol. Chem. 280, 9400–9408.
Liang, F., Huang, Z., Lee, S.-Y., et al. (2003) Aurintricarboxylic acid blocks both in vitro and in vivo activity of YopH, an essential virulent factor from Yersinia that cause the plague. J. Biol. Chem. 278, 41,734–41,741.
Lazo, J. S. and Wipf, P. (2003) Small molecule regulation of phosphatase-dependent cell signaling pathways. Oncol. Res. 13, 347–352.
Ducruet, A. P., Vogt, A., Wipf, P., and Lazo, J. (2005) Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer’s disease. Annu. Rev. Pharmacol. Toxicol. 45, 725–750.
Pellecchia, M., Becattini, B., Crowell, K. J., Fattorusso, R., Forino, M., Fragai, M., Jung, D., Mustelin, T., and Tautz, L. (2004) NMR-based techniques in the hit identification and optimization process. Expert Opin. Ther. Targets 8, 597–611.
Umezawa, K., Kawakami, M., and Watanabe, T. (2003) Molecular design and biological activities of protein-tyrosine phosphatase inhibitors. Pharmacol. Ther. 99, 15–24.
Li, X., Bhandari, A., Holmes, C. P., and Szardenings, A. K. (2004) Alpha,alpha-difluoro-beta-ketophosphonates as potent inhibitors of protein tyrosine phosphatase 1B. Bioorg. Med. Chem. Lett. 14, 4301–4306.
Bialy, L. and Waldmann, H. (2005) Inhibitors of protein tyrosine phosphatases: next-generation drugs? Angew. Chem. Int. Ed. Engl., 44, 3814–3839.
Pei, Z., Liu, G., Lubben, T. H., and Szczepankiewicz, B. G. (2004) Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity. Curr. Pharm. Des. 10, 3481–3504.
Black, E., Breed, J., Breeze, A.L., et al. (2005) Structure-based design of protein tyrosine phosphatase-1B inhibitors. Bioorg. Med. Chem. Lett. 15, 2503–2507.
Kumar, S., Zhou, B., Liang, F., Wang, W. Q., Huang, Z., and Zhang, Z.-Y. (2004) Activity-based probes for protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 101, 7943–7948.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Mustelin, T. (2007). A Brief Introduction to the Protein Phosphatase Families. In: Moorhead, G. (eds) Protein Phosphatase Protocols. Methods in Molecular Biology, vol 365. Springer, Totowa, NJ. https://doi.org/10.1385/1-59745-267-X:9
Download citation
DOI: https://doi.org/10.1385/1-59745-267-X:9
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-1-58829-711-2
Online ISBN: 978-1-59745-267-0
eBook Packages: Springer Protocols